Ultimately, individual experiences can vary greatly, and you may find you tolerate one drug's side effect profile better than the other's
Results Timelines The following timeline is based on community reports and clinical observations rather than controlled trials
How This Compares to Similar Drugs Tirzepatide's Phase 3 trials began in 2019, FDA submission happened in mid-2022, and approval came in May 2022 (for diabetes) and November 2023 (for obesity)
This process not only supports weight loss but also helps optimize energy production by converting stored fat into usable fuel
Majalah Kedokteran Bandung
FDA-Approved Safe & effective Medical Support Expert guidance Proven Results Real transformations Trusted by hundreds of satisfied patients Choose from proven, physician-supervised weight loss medications that deliver real, sustainable results